Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults – VISION Network, Nine States, September-November 2022. 12/29/22. Tenforde MW. MMWR Morb Mortal Wkly Rep.

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults – VISION Network, Nine States, September-November 2022. 12/29/22. Tenforde...

Association of Time to Surgery After COVID-19 Infection With Risk of Postoperative Cardiovascular Morbidity. 12/14/2022. Bryant JM. JAMA Netw Open.

Association of Time to Surgery After COVID-19 Infection With Risk of Postoperative Cardiovascular Morbidity. 12/14/2022. Bryant JM. JAMA Netw Open. This retrospective study from Vanderbilt was conducted among 3997 adult patients with a history of COVID-19, who were...

Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System : A Population-Based Cohort Study. 12/12/22. Dryden-Peterson S. Ann Intern Med.

Nirmatrelvir Plus Ritonavir for Early COVID-19 in a Large U.S. Health System : A Population-Based Cohort Study. 12/12/22. Dryden-Peterson S. Ann Intern Med. This study was designed to assess the real-world efficacy of nirmatrelvir plus ritonavir (Paxlovid) for early...

Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 — United States, April–September 2022. 12/2/22. Shah M. MMWR Morb Mortal Wkly Rep.

Paxlovid Associated with Decreased Hospitalization Rate Among Adults with COVID-19 — United States, April–September 2022. 12/2/22. Shah M. MMWR Morb Mortal Wkly Rep. This study reviewed electronic medical records to show that of 699,848 adults aged ≥18 years who were...

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. 12/29/22. Wang Q. Cell.

Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. 12/29/22. Wang Q. Cell. This is a detailed in-vitro study of antibody resistance and viral receptor binding affinity of SARS-CoV-2 Omicron BQ.1, BQ.1.1, XBB, and XBB.1 subvariants, that...

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years – IVY Network, 18 States, September 8-November 30, 2022. 12/29/22. Surie D. MMWR Morb Mortal Wkly Rep.

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19-Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years – IVY Network, 18 States, September 8-November 30, 2022. 12/29/22. Surie D. MMWR Morb Mortal Wkly Rep. These IVY...